AlloVir, Inc. (ALVR) closed the last trading session at $5.43, gaining 14.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...
AlloVir (NASDAQ:ALVR) layoffs are in the news after the clinical-stage cell therapy company announced a massive number of job cuts. AlloVir has revealed that a new round of layoffs will have it ...
NEW YORK, Jan. 22, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results